Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions

被引:46
作者
Seilhean, D
Takahashi, J
El Hachimi, KH
Fujigasaki, H
Lebre, AS
Biancalana, V
Dürr, A
Salachas, F
Hogenhuis, J
de Thé, H
Hauw, JJ
Meininger, V
Brice, A
Duyckaerts, C
机构
[1] Hop La Pitie Salpetriere, Assoc Claude Bernard, INSERM, U360,Lab Neuropathol Raymond Escourolle, F-75651 Paris 13, France
[2] Hop La Pitie Salpetriere, INSERM, U289, Paris 13, France
[3] Hop La Pitie Salpetriere, Div Mazarin, Federat Neurol, Paris 13, France
[4] Fac Med Strasbourg, Lab Diagnost Genet, Strasbourg, France
[5] Hop St Louis, Lab Biochim B, CNRS, UPR 9051, Paris 10, France
[6] Jikei Univ, Sch Med, Div Neuropathol, Tokyo, Japan
[7] Hop La Pitie Salpetriere, INSERM, U106, Paris 13, France
关键词
amyotrophic lateral sclerosis; protein inclusions;
D O I
10.1007/s00401-004-0855-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 46-year-old patient developed amyotrophic lateral sclerosis (ALS) characterized by rapid progression. She needed respiratory assistance after a course of 9 months. She died 4.5 years after onset. Autopsy showed dramatic atrophy of the spinal cord, sparing only the posterior tracts, associated with neuronal loss and astrogliosis in various areas including the anterior horns, motor cortex, striatum, thalamus, and substantia nigra. Ubiquitin immunohistochemistry showed rare skein-like inclusions in the surviving spinal and medullary motor neurons. Eosinophilic inclusions were found in the nuclei of pyramidal neurons in the hippocampus. These inclusions were immunoreactive to antibodies against ubiquitin, promyelocytic leukemia gene product, proteasome, and ataxin-3. They were not immunoreactive to antibodies against tau, cystatin C, neurofilament, alpha-synuclein, SOD-1, and polyglutamine (1C2), and were not stained by ethidium bromide. Similar inclusions were found in the motor cortex. The immunoreactivity of the inclusions was similar to that encountered in diseases associated with CAG repeats, except for the negativity of the immunolabelling with 1C2. At the ultrastructural level, the nuclear inclusions were made of straight filaments (10-12 nm in diameter) arranged at random, reminiscent of the polyglutamine intranuclear hyaline inclusions.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 38 条
[1]  
BUNINA TL, 1962, KORSAKOV J NEUROPATH, V62, P1293
[2]   EXTRACTION OF DNA FROM SMALL SECTIONS OF FROZEN TISSUE WITH SIMULTANEOUS HISTOLOGICAL EXAMINATION [J].
COTTER, FE ;
HALL, PA ;
YOUNG, BD .
JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (10) :1125-1126
[3]  
DANIEL MT, 1993, BLOOD, V82, P1858
[4]   Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? [J].
Davies, SW ;
Beardsall, K ;
Turmaine, M ;
DiFiglia, M ;
Aronin, N ;
Bates, GP .
LANCET, 1998, 351 (9096) :131-133
[5]   FE65 in Alzheimer's disease - Neuronal distribution and association with neurofibrillary tangles [J].
Delatour, B ;
Mercken, L ;
El Hachimi, KH ;
Colle, MA ;
Pradier, L ;
Duyckaerts, C .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (05) :1585-1591
[6]  
Delisle MB, 2001, J NEUROPATH EXP NEUR, V60, P514
[7]   Regulatory subunit interactions of the 26S proteasome, a complex problem [J].
Ferrell, K ;
Wilkinson, CRM ;
Dubiel, W ;
Gordon, C .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (02) :83-88
[8]   Ubiquitination: RING for destruction? [J].
Freemont, PS .
CURRENT BIOLOGY, 2000, 10 (02) :R84-R87
[9]   Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains [J].
Fujigasaki, H ;
Uchihara, T ;
Koyano, S ;
Iwabuchi, K ;
Yagishita, S ;
Makifuchi, T ;
Nakamura, A ;
Ishida, K ;
Toru, S ;
Hirai, S ;
Ishikawa, K ;
Tanabe, T ;
Mizusawa, H .
EXPERIMENTAL NEUROLOGY, 2000, 165 (02) :248-256
[10]   Preferential recruitment of ataxin-3 independent of expanded polyglutamine: an immunohistochemical study on Marinesco bodies [J].
Fujigasaki, H ;
Uchihara, T ;
Takahashi, J ;
Matsushita, H ;
Nakamura, A ;
Koyano, S ;
Iwabuchi, K ;
Hirai, S ;
Mizusawa, H .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 71 (04) :518-520